-
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
16 Jun 2025 12:00 GMT
… Drug Administration (FDA) has updated the Approved Drug … About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a … of novel treatments for gastrointestinal diseases … tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® …
-
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
06 Jun 2025 16:27 GMT
… S. Food and Drug Administration (FDA) has approved … About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a … commercialization of novel treatments for gastrointestinal diseases. … tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® …
-
Phathom Soars 95% on FDA Exclusivity for VOQUEZNA
06 Jun 2025 21:15 GMT
… treatment market.
Phathom Pharmaceuticals … treatments for gastrointestinal diseases. The U.S. Food and Drug Administration (FDA … clarithromycin tablets) and DUAL PAK (vonoprazan tablets, amoxicillin capsules). Unlike traditional treatments … biotech landscape …
-
Extrapulmonary Comparisons Between Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria: From Manifestations and Diagnosis to Treatment
21 May 2025 22:05 GMT
… , rifabutin or ethambutol). Clarithromycin is usually the drug of choice because of … medication regimens are often based on the particular species of mycobacteria, drug … of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the …
-
Dulera interactions: Alcohol, medications, and other factors
19 May 2025 15:17 GMT
… in detail in “Drug interactions in depth … your doctor or pharmacist.
Clarithromycin
Taking clarithromycin with Dulera … medication you’re taking.
Thyroid problems: Before starting Dulera treatment, tell your doctor … been enough clinical trials to determine …
-
Successful Treatment of Cutaneous Foreign Body Granuloma with JAK Inhibitor Abrocitinib and Prednisone: A Case Report
17 May 2025 12:19 GMT
… adverse drug reactions were reported throughout the therapeutic course.
Figure 2 Treatment … use of medications that are also metabolized by CYP3A4 (clarithromycin, econazole, … further mechanistic studies and controlled trials are warranted to optimize JAK …
-
Cutaneous Granuloma Resulting from Mixed Infection with Mycobacterium marinum and Candida metapsilosis: A Case Report of Successful Treatment
17 May 2025 12:19 GMT
… two weeks after discontinuing the medication. The patient had no … illness, renal disease, or drug allergies except for hypertension. Physical … and absence of controlled trials.2 Monotherapy is generally … a 10-day oral clarithromycin treatment and a 3-month …
-
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
15 May 2025 12:00 GMT
… S. Food and Drug Administration (FDA) has approved Brekiya … prescription medicine used for the acute treatment of … nelfinavir, indinavir, erythromycin, clarithromycin, ketoconazole, or itraconazole.
… Pharmaceuticals LLC at 1-877-835-5472, or FDA at 1-800-FDA …
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
15 May 2025 11:59 GMT
… developing and commercializing novel treatments for gastrointestinal (GI) … meeting. About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical … vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL …
-
Treatment Strategies for Tardive Dyskinesia
14 May 2025 16:02 GMT
… treatment of TD, there were no FDA-approved medications for its treatment … CYP3A4 (e.g., clarithromycin, ketoconazole) or 2D6 … Trials Major trials involving deutetrabenazine for the treatment … Wales, PA: Teva Pharmaceuticals USA, Inc; April 2017.
…
About
© 1995-2025